Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GSK · against 41 other Healthcare companies of similar size
Ranked #9 of 42 · scores higher than 76% of peers
Bars: peers in each 10-point band of the growth score9 peers with a growth score of 70–79, including GSK · Click a bar to see the companies
Mainly thanks to its earnings per share growth, which is stronger than most Healthcare peers.
| Metric | GSK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 42 reported | 4.1% | 8.3% | 15% | 33% | |
| Earnings per share growthHigher is better · 35 reported | 121.9% | 18.7% | 94% | 33% | |
| 3-year revenue growthHigher is better · 42 reported | 3.7% | 6.3% | 20% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 56.7B USD | 96 | 79 | |
| 2 | 56.0B USD | 86 | 39 | |
| 3 | 126.5B USD | 78 | 56 | |
| 4 | 534.1B HKD (≈$68.4B) | 76 | 75 | |
| 4 | 48.9B USD | 76 | 54 | |
| 4 | 52.7B EUR (≈$58.0B) | 76 | 71 | |
| 7 | 63.0B USD | 73 | 65 | |
| 7 | 155.7B USD | 73 | 64 | |
| 9 | 540.4B BRL (≈$97.3B) | 72 | 64 | |
| 9 | 97.5B USD | 72 | 67 | |
| 9 | 162.93T ARS (≈$162.9B) | 72 | 63 | |
| 12 | 116.5B USD | 69 | 57 | |
| 12 | 49.1B USD | 69 | 69 | |
| 14 | 78.1B USD | 64 | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score